Larotrectinib
Brand name: Vitrakvi
Larotrectinib comes in 6 pill versions in our database, in 2 strengths, from 3 manufacturers. Check the imprint to tell them apart.
Larotrectinib pill images
25 mg 3 pills
- LOXO LARO 25mg Larotrectinib 25 mg White, capsule, 18 mm Used for neoplasm metastasis
- BAYER 25mg Larotrectinib 25 mg White, capsule, 18 mm Used for neoplasm metastasis
- No picture yet DIN 02490315 Larotrectinib Sulfate 25 mg Vitrakvi, Capsule, sold in Canada Used for neoplasm metastasis
100 mg 3 pills
What is Larotrectinib used for?
Larotrectinib is used for neoplasm metastasis.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
VITRAKVI is indicated for the treatment of adult and pediatric patients with solid tumors that:
- have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation,
- are metastatic or where surgical resection is likely to result in severe morbidity, and
- have no satisfactory alternative treatments or that have progressed following treatment.
Select patients for therapy based on an FDA-approved test.
From the FDA-approved label on DailyMed (published May 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.